Prof. Dr. VEDAT HAMURYUDAN

Yayın Ağı

Makaleler 189

1. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

RHEUMATOLOGY , cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Development of Posterior Uveitis in Behçet Syndrome Patients with Vitreous Cells at Baseline

Uçar D., Bircan B. E., Rustamli N., Batu Oto B., Hamuryudan V., Hatemi G., et al.

Ocular Immunology and Inflammation , cilt.33, sa.2, ss.243-249, 2025 (SCI-Expanded, Scopus)

3. Validation of the Behçet's Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modification

Ozogul Y. Y., ÖZGÜLER Y., ESATOĞLU S. N., UÇAR D., UYGUNOĞLU U., KUTLUBAY Z., et al.

RHEUMATOLOGY , 2024 (SCI-Expanded, Scopus)

4. Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis

UÇAR D., ESATOĞLU S. N., Cerme E., BATU OTO B., Hamuryudan V., SEYAHİ E., et al.

Rheumatology International , cilt.43, sa.11, ss.2099-2106, 2023 (SCI-Expanded, Scopus)

5. Development of Posterior Uveitis in Behcet's Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement

UÇAR D., Bircan B. E., RUSTAMLI N., BATU OTO B., HAMURYUDAN V., ESATOĞLU S. N., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3072-3073, 2023 (SCI-Expanded, Scopus)

6. Central Nervous System Involvement and Mimickers in ANCA Associated Vasculitis

Ozogul Y. Y., ESATOĞLU S. N., Ozogul M., KIZILKILIÇ O., ÖZGÜLER Y., Uygunoglu U., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3063-3065, 2023 (SCI-Expanded, Scopus)

7. De Novo Manifestations During Adalimumab Treatment in Behcet Syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3070-3072, 2023 (SCI-Expanded, Scopus)

8. Romatoid artritli hastalarda tocilizumab deneyimi: Geriye dönük çalışma

ERDOĞAN M., HAMURYUDAN V., Günaltılı M.

Ulusal Romatoloji Dergisi , cilt.15, sa.1, ss.25-29, 2023 (Scopus, TRDizin)

9. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., YURDAKUL S., HAMURYUDAN V., et al.

RHEUMATOLOGY , cilt.62, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Development of Posterior Uveitis in Behcet's Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement

UÇAR D., Bircan B. E., RUSTAMLI N., BATU OTO B., HAMURYUDAN V., ESATOĞLU S. N., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3090-3091, 2022 (SCI-Expanded, Scopus)

11. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., TÜKEK N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3098-3099, 2022 (SCI-Expanded, Scopus)

12. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine

Ozdede A., GÜNER S., Ozcifci G., YURTTAŞ B., TOKER DİNCER Z., Atli Z., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, ss.973-987, 2022 (SCI-Expanded, Scopus)

13. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behcet's syndrome

Ozcifci G., Aydin T., Atli Z., BALKAN İ. İ., TABAK Ö. F., ÖZTAŞ M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.1, ss.101-113, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly

SEYAHİ E., BAKHDIYARLI G., ÖZTAŞ M., KUŞKUCU M. A., TOK Y., SÜT N., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.8, ss.1429-1440, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey

YURTTAŞ B., POYRAZ B. Ç., SÜT N., Ozdede A., ÖZTAŞ M., UĞURLU S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.6, ss.1105-1114, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. COVID-19 Among Patients With Inflammatory Rheumatic Diseases

Esatoglu S. N., Tascilar K., Babaoglu H., Bes C., YURTTAŞ B., AKAR S., et al.

FRONTIERS IN IMMUNOLOGY , cilt.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Guzelant G., Ucar D., Esatoglu S. N., Hatemi G., Ozyazgan Y., Yurdakul S., et al.

Clinical and experimental rheumatology , sa.6, ss.86-89, 2017 (SCI-Expanded, Scopus)

18. MiRNA and mRNA Profiling in Systemic Lupus Reveals a Novel Set of Cytokine - Related miRNAs and their Target Genes in Cases With and Without Renal Involvement

Ghods F. J., Sarikaya A. T., Arda N., Hamuryudan V.

KIDNEY & BLOOD PRESSURE RESEARCH , cilt.42, sa.6, ss.1322-1337, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci Ş., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.36, sa.12, ss.1719-1725, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behcet's syndrome patients with pulmonary artery involvement during follow-up

Esatoglu S. N., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

21. One year in review 2016: Belicet's syndrome

Hatemi G., Seyahi E., Fresko İ., TALARICO R., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

22. AN OUTCOME SURVEY OF 100 PATIENTS WITH CEREBRAL VENOUS SINUS THROMBOSIS DUE TO BEHCET'S SYNDROME FOLLOWED UP AT A SINGLE, DEDICATED CENTER

KURT E., Kocer N., Ozguler Y., UÇAR D., Uygunoglu U., Islak C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

23. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu N. S., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

24. Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey

Hamuryudan V., Direskeneli H., Ertenli I., Inanc M., Karaaslan Y., Oksel F., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, ss.1033-1037, 2016 (SCI-Expanded, Scopus)

25. Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients

Guzelant G., Melikoglu M., Musellim B., Yilmaz D. D., Fresko I., Seyahi E., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

26. Infliximab is a plausible alternative for neurologic complications of Behcet disease

Zeydan B., Uygunoglu U., Saip S., Demirci O. N., Seyahi E., Ugurlu S., et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , cilt.3, sa.5, 2016 (SCI-Expanded, Scopus)

27. An Outcome Survey of 100 Patients with Cerebral Venous Sinus Thrombosis Due to Behcet's Syndrome Followed up at a Single, Dedicated Center

Kurt E. A., Kocer N., ÖZGÜLER Y., UÇAR D., UYGUNOĞLU U., Islak C., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

28. Pulmonary artery involvement in Behçet's syndrome: Effects of anti-Tnf treatment

Hamuryudan V., Seyahi E., Ugurlu S., Melikoglu M., Hatemi G., Ozguler Y., et al.

Seminars in Arthritis and Rheumatism , cilt.45, sa.3, ss.369-373, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Suicidal ideation among patients with Behcet's syndrome

Saygin C., Uzunaslan D., Hatemi G., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Behcet's syndrome: a critical digest of the 2014-2015 literature

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Work Disability over Time in Behcet's Syndrome

Hatemi G., Tascilar K., Ozguler Y., Ugurlu S., Hamuryudan V.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

32. Tocilizumab Is Effective in the Treatment of AA Amyloidosis Secondary to Familial Mediterranean Fever

Ozdogan H., Ugurlu S., Hacioglu A., Adibnia Y., Hamuryudan V.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

33. Bronchial Artery Enlargement May Cause Recurring Hemoptysis in Behcet's Syndrome Patients with Pulmonary Artery Involvement Despite Response to Treatment

Hamuryudan V., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

34. Takayasu's Arteritis Associated with Behcet's Syndrome: A Case Series of 8 Patients

Esatoglu S. N., Seyahi E., Ugurlu S., Hatemi G., Melikoglu M., Hamuryudan V., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

35. Can We Differentiate Takayasu's Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?

UĞURLU S., KESKİN F. E., CETINKAYA F., MELİKOĞLU M., HAMURYUDAN V., FRESKO İ., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

36. Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey

AKKOÇ N., Direskeneli H., Erdem H., Gül A., KABASAKAL Y., KİRAZ S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.35, sa.9, ss.1473-1478, 2015 (SCI-Expanded, Scopus)

37. Restarting biologic agents in rheumatology patients who developed tuberculosis under TNF alpha-inhibitor treatment

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci S., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.46, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Tuberculosis in patients receiving treatment of TNF-alpha inhibitors

Borekci S., Yilmaz D. D., Atahan E., Ozguler Y., Musellim B., Hamuryudan V., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.46, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. BRONCHIAL ARTERY ENLARGEMENT MAY BE THE CAUSE OF RECURRING HEMOPTYSIS IN BEHCET'S SYNDROME PATIENTS WITH PULMONARY ARTERY INVOLVEMENT DESPITE TREATMENT RESPONSE

Hamuryudan V., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.304, 2015 (SCI-Expanded, Scopus)

40. WORK DISABILITY OVER TIME IN BEHCET'S SYNDROME PATIENTS

Hatemi G., Tascilar K., Ozguler Y., Ugurlu S., Hamuryudan V.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.298-299, 2015 (SCI-Expanded, Scopus)

41. MALIGNANCIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF-ALPHA ANTAGONISTS

Ozguler Y., Esatoglu S. N., Keskin D., Hatemi G., Hamuryudan V., Pala A. S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1040, 2015 (SCI-Expanded, Scopus)

42. HOW CORRECT ARE THE ASSUMPTIONS MADE DURING THE DEVELOPMENT OF TUBERCULOSIS SCREENING ALGORYTHMS BEFORE TNF-ALPHA ANTAGONISTS?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H., Tascilar E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.702, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. RESTARTING BIOLOGICS IN PATIENTS WHO DEVELOPED TUBERCULOSIS DURING ANTI TNF-ALPHA TREATMENT

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.472, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behcet's syndrome followed up at a single, dedicated center

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.44, sa.5, ss.602-609, 2015 (SCI-Expanded, Scopus)

45. Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment.

Borekci S., Atahan E., Yilmaz D. D., Mazican N., Duman B., Ozguler Y., et al.

Respiration; international review of thoracic diseases , cilt.90, sa.3, ss.191-8, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. How Correct Are the Assumptions Made for Tuberculosis Screening Algorythms before TNF-Alpha Antagonists?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H. D., Tascilar E. K., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Melikoglu M., Ozguler Y., Ugurlu S., Cetinkaya F., Tascilar K., Seyahi E., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

48. Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever.

Ozdogan H., UĞURLU S., Hacioglu A., Adibnia Y., HAMURYUDAN V.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

49. Anti-TNF Treatment for Refractory Vascular Involvement of Behcet's Syndrome.

Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

50. Budd-Chiari Syndrome Due to Behcet's Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome.

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

51. Behcet's syndrome: a critical digest of the 2013-2014 literature

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Impact of rheumatoid arthritis in Turkey: a questionnaire study

Direskeneli H., Akkoc N., Bes C., Cakir N., Cefle A., Cobankara V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, ss.477-483, 2014 (SCI-Expanded, Scopus)

53. Outcome Measures Used in Clinical Trials for Behcet Syndrome: A Systematic Review

Hatemi G., Merkel P. A., Hamuryudan V., Boers M., Direskeneli H., Aydin S. Z., et al.

JOURNAL OF RHEUMATOLOGY , cilt.41, sa.3, ss.599-612, 2014 (SCI-Expanded, Scopus)

54. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome

Ozguler Y., Melikoglu M., Ugurlu S., Cetinkaya F., Tascilar E. K., Seyahi E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

55. Colchicine in behçet syndrome: A longterm survey of patients in a controlled trial

Hamuryudan V., Hatemi G., Tascilar K., Yurdakul S., Mat C., Ozyazgan Y., et al.

Journal of Rheumatology , cilt.41, sa.4, ss.735-738, 2014 (SCI-Expanded, Scopus)

56. Self-criticism in Behçet's disease and other autoinflammatory conditions

Yazici H., Talarico R., Hamuryudan V.

Clinical and Experimental Rheumatology , cilt.32, 2014 (SCI-Expanded, Scopus)

57. The relationship between smoking habit and tuberculosis in patients under anti-TNF-alpha treatment

Borekci S., Duman B., Mazican N., Atahan E., Musellim B., Ongen G., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.42, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. INFLIXIMAB FOR SIGHT-THREATENING AND REFRACTORY UVEITIS OF BEHCET'S SYNDROME

Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.488, 2013 (SCI-Expanded, Scopus)

59. INDIRECT COSTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS IN TURKEY

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.1029, 2013 (SCI-Expanded, Scopus)

60. MEDICAL COSTS OF PATIENTS WITH RHEUMATOID ARTHRITIS AND ASSOCIATION WITH GLOBAL DISEASE ACTIVITY IN TURKEY

Hamuryudan V., Direskeneli H., Ertenli I., Inanc M., Karaaslan Y., Oksel F., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.777, 2013 (SCI-Expanded, Scopus)

61. CAUSES OF HOSPITALISATION IN BEHCET'S SYNDROME OVER A TEN-YEAR PERIOD

Ozguler Y., Pala A. S., Hamuryudan V., Hatemi G., Yurdakul S., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.936, 2013 (SCI-Expanded, Scopus)

62. PRODUCTIVITY LOSS DUE TO SICK LEAVE IN PATIENTS WITH ANKYLOSING SPONDYLITIS

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.662-663, 2013 (SCI-Expanded, Scopus)

63. CURRENT THERAPY OF RHEUMATOID ARTHRITIS IN TURKEY: RHEUMATOLOGISTS' PERSPECTIVE

Kamali S., Pay S., Inanc N., Simsek I., HAMURYUDAN V.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.437, 2013 (SCI-Expanded, Scopus)

64. Behcet's syndrome: a critical digest of the 2012-1213 literature

Hatemi G., Seyahi E., Fresko I., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.31, sa.3, 2013 (SCI-Expanded, Scopus)

65. Acute phase response and oxidative stress status in familial Mediterranean fever (FMF)

Guzel S., Andican G., Seven A., Aslan M., Bolayirli M., Guzel E. C., et al.

MODERN RHEUMATOLOGY , cilt.22, sa.3, ss.431-437, 2012 (SCI-Expanded, Scopus)

66. Behcet's syndrome: a critical digest of the recent literature

Hatemi G., Seyahi E., Fresko İ., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.30, sa.3, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Frequent oral ulceration during early disease may predict a severe disease course in males with Behcet's syndrome

Hamuryudan V., Hatemi G., Sut N., Ugurlu S., Yurdakul S., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.30, sa.3, 2012 (SCI-Expanded, Scopus)

68. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey

Malhan S., Pay S., Ataman S., DALKILIÇ H. E., Dinc A., ERKEN E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.30, sa.2, ss.202-207, 2012 (SCI-Expanded, Scopus)

69. Pulmonary Artery Involvement and Associated Lung Disease in Behcet Disease A Series of 47 Patients

Seyahi E., Melikoglu M., Akman C., Hamuryudan V., Ozer H., Hatemi G., et al.

MEDICINE , cilt.91, sa.1, ss.35-48, 2012 (SCI-Expanded, Scopus)

70. Management and prognosis of nonpulmonary large arterial disease in patients with Behcet disease

Tuzun H., Seyahi E., Arslan C., Hamuryudan V., Besirli K., Yazici H.

JOURNAL OF VASCULAR SURGERY , cilt.55, sa.1, ss.157-163, 2012 (SCI-Expanded, Scopus)

71. THE COST OF CARE OF RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS IN TERTIARY CARE RHEUMATOLOGY UNITS IN TURKEY

Malhan S., Pay S., Ataman S., Dalkilic E., Dinc A., Erken E., et al.

VALUE IN HEALTH , cilt.14, sa.7, 2011 (SCI-Expanded, SSCI, Scopus)

72. The estimated pulmonary artery pressure can be elevated in Behcet's syndrome

Seyahi E., Baskurt M., Melikoglu M., Akman C., Olgun D., Simsek E., et al.

RESPIRATORY MEDICINE , cilt.105, sa.11, ss.1739-1747, 2011 (SCI-Expanded, Scopus)

73. Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire

Haraoui B., Smolen J. S., Aletaha D., Breedveld F. C., Burmester G., Codreanu C., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.70, sa.11, ss.1999-2002, 2011 (SCI-Expanded, Scopus)

74. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists

Gossec L., Bijlsma J. W. J., Bombardier C., Canhao H., Devlin J., Edwards C. J., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.70, sa.2, ss.388-389, 2011 (SCI-Expanded, Scopus)

75. Analyses of functional IL10 and TNF-alpha genotypes in Behcet's syndrome

Ates O., Dalyan L., Hatemi G., Hamuryudan V., Topal-Sarikaya A.

MOLECULAR BIOLOGY REPORTS , cilt.37, sa.7, ss.3637-3641, 2010 (SCI-Expanded, Scopus)

76. EFFICACY AND SAFETY OF TNF-ALPHA ANTAGONISTS IN THE MANAGEMENT OF BEHCET'S SYNDROME: A SYSTEMATIC REVIEW

Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

77. WORK DISABILITY IN BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Ugurlu S., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

78. CURRENT TRENDS IN THE MANAGEMENT OF BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Yurdakul S., Fresko I., Melikoglu M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

79. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME (BS)

Hamuryudan V., Hatemi G., Yurdakul S., Tascilar K., Mat C., Ozyazgan Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

80. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

81. Interferon therapy in rheumatic diseases: state-of-the-art 2010

Koetter I., Hamuryudan V., Ozturk Z. E., Yazici H.

CURRENT OPINION IN RHEUMATOLOGY , cilt.22, sa.3, ss.278-283, 2010 (SCI-Expanded, Scopus)

82. Vascular Disease in Behcet's Syndrome

Hamuryudan V., Melikoglu M.

BEHCET'S SYNDROME , ss.115-133, 2010 (SCI-Expanded)

83. Medical Management of Behcet's Syndrome

Hamuryudan V., Koetter I.

BEHCET'S SYNDROME , ss.317-338, 2010 (SCI-Expanded)

84. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial

Hamuryudan V., Hatemi G., Tascilar K., Sut N., Ozyazgan Y., Seyahi E., et al.

RHEUMATOLOGY , cilt.49, sa.1, ss.173-177, 2010 (SCI-Expanded, Scopus)

85. Efficacy and safety of TNF-alpha antagonists in the management of Behcet's syndrome - a systematic survey

Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.27, sa.5, ss.736, 2009 (SCI-Expanded, Scopus)

86. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

Visser K., Katchamart W., Loza E., Martinez-Lopez J. A., Salliot C., Trudeau J., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.68, sa.7, ss.1086-1093, 2009 (SCI-Expanded, Scopus)

87. Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis

Seven A., Guzel S., Aslan M., Hamuryudan V.

RHEUMATOLOGY INTERNATIONAL , cilt.29, sa.7, ss.743-747, 2009 (SCI-Expanded, Scopus)

88. Genetic susceptibility to Beh double dagger et's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients

Ates O., Dalyan L., Hatemi G., Hamuryudan V., Topal-Sarikaya A.

RHEUMATOLOGY INTERNATIONAL , cilt.29, sa.7, ss.787-791, 2009 (SCI-Expanded, Scopus)

89. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis

Ates O., Dalyan L., Musellim B., Hatemi G., Tuerker H., Oengen G., et al.

INTERNATIONAL JOURNAL OF IMMUNOGENETICS , cilt.36, sa.1, ss.15-19, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

90. Comment on "Cardiac Behcet Disease Presenting as Aortic Valvulitis/Aortitis or Right Heart Inflammatory Mass: A Clinicopathologic Study of 12 Cases"

Hamuryudan V., Seyahi E., Yazici H.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY , cilt.32, sa.12, ss.1914-1915, 2008 (SCI-Expanded, Scopus)

91. Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients

Ates O., Hatemi G., Hamuryudan V., Topal-Sarikaya A.

CLINICAL RHEUMATOLOGY , cilt.27, sa.10, ss.1243-1248, 2008 (SCI-Expanded, Scopus)

92. Atherosclerosis in Behcet's syndrome

Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.38, sa.1, ss.1-12, 2008 (SCI-Expanded, Scopus)

93. THE LONG TERM PROGNOSIS OF BEHCET'S SYNDROME AMONG MEN WITH SKIN-MUCOSA INVOLVEMENT AT ONSET: RE-EVALUATION OF A COHORT OF PATIENTS ENROLLED IN A CONTROLLED TRIAL

Hamuryudan V., Hatemi G., Tascilar K., Ozyazgan Y., Seyahi E., Mat C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

94. LARGE VESSEL INVOLVEMENT IN BEHCET'S SYNDROME: A RETROSPECTIVE SURVEY

Melikoglu M., Ugurlu S., Tascilar K., Caglar F., Seyahi F., Hamuryudan V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

95. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis

Seven A., Guzel S., Aslan M., Hamuryudan V.

CLINICAL BIOCHEMISTRY , cilt.41, ss.538-543, 2008 (SCI-Expanded, Scopus)

96. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists

Sidiropoulos P. I., Hatemi G., Song I. -., Avouac J., Collantes E., Hamuryudan V., et al.

RHEUMATOLOGY , cilt.47, sa.3, ss.355-361, 2008 (SCI-Expanded, Scopus)

97. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease

Direskeneli H., Ergun T., Yavuz S., Hamuryudan V., Eksioglu-Demiralp E.

CLINICAL RHEUMATOLOGY , cilt.27, sa.3, ss.373-375, 2008 (SCI-Expanded, Scopus)

98. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome

Seyahi E., Hamuryudan V., Hatemi G., Melikoglu M.

RHEUMATOLOGY , cilt.46, sa.7, ss.1213-1214, 2007 (SCI-Expanded, Scopus)

99. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome

Fresko İ., Ugurlu S., Ozbakir F., Celik A. F., Yurdakul S., Hamuryudan V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.23, sa.4, 2005 (SCI-Expanded, Scopus)

100. Headache in Behcet's syndrome

Saip S., Siva A., Altintas A., Kiyat A., Seyahi E., Hamuryudan V., et al.

HEADACHE , cilt.45, sa.7, ss.911-919, 2005 (SCI-Expanded, Scopus)

101. Fibrinolytic activity and d-dimer levels in Behcet's syndrome

Yurdakul S., Hekim N., Soysal T., Fresko I., Bavunoglu I., Ozbakir F., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.23, sa.4, 2005 (SCI-Expanded, Scopus)

102. Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behcet's disease

Direskeneli H., Fresko İ., Hamuryudan V.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.34, sa.1, ss.75-76, 2005 (SCI-Expanded, Scopus)

103. Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al.

JOURNAL OF RHEUMATOLOGY , cilt.32, sa.1, ss.98-105, 2005 (SCI-Expanded, Scopus)

104. Pulmonary artery aneurysms in Behcet syndrome

Hamuryudan V., Er T., Seyahi E., Akman C., Tuzun H., Fresko İ., et al.

AMERICAN JOURNAL OF MEDICINE , cilt.117, sa.11, ss.867-870, 2004 (SCI-Expanded, Scopus)

105. Coronary atherosclerosis in Behcet's syndrome: a pilot study using electron-beam computed tomography

Seyahi E., Memisoglu E., Hamuryudan V., Tepe S., Aker U., Balci H., et al.

RHEUMATOLOGY , cilt.43, sa.11, ss.1448-1450, 2004 (SCI-Expanded, Scopus)

106. The menacing pulmonary artery aneurysms of Behçet's syndrome.

HAMURYUDAN V., Oz B., TUZUN H. H., YAZICI H.

Clinical and experimental rheumatology , cilt.22, 2004 (SCI-Expanded, Scopus)

107. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study

Tunc R., Gonen M., Acbay Ö., Hamuryudan V., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES , cilt.63, sa.5, ss.575-577, 2004 (SCI-Expanded, Scopus)

108. Behçet syndrome

Yurdakul S., HAMURYUDAN V., Yazici H.

Current Opinion in Rheumatology , cilt.16, sa.1, ss.38-42, 2004 (SCI-Expanded, Scopus)

109. Invited editor: Rules for writing the medical manuscript Tibbi Makale Yazim Kurallari

HAMURYUDAN V.

Anadolu Kardiyoloji Dergisi , cilt.3, sa.3, ss.199, 2003 (SCI-Expanded, Scopus, TRDizin)

110. Enteroclysis findings of intestinal Behcet disease: A comparative study with Crohn disease

Korman U., Cantasdemir M., Kurugoglu S., mihmanli I., Soylu N., hamuryudan v., et al.

Abdominal Imaging , cilt.28, sa.3, ss.308-312, 2003 (SCI-Expanded, Scopus)

111. The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center

Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., et al.

MEDICINE , cilt.82, sa.1, ss.60-76, 2003 (SCI-Expanded, Scopus)

112. Superoxide dismutase activity and glutathione system in erythrocytes of men with Behchet's disease

Dincer Y., Alademir Z., Hamuryudan V., Fresko İ., Akcay T.

Tohoku Journal of Experimental Medicine , cilt.198, sa.3, ss.191-195, 2002 (SCI-Expanded, Scopus)

113. Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: An open study

Hamuryudan V., Ozyazgan Y., Fresko Y., Mat C., Yurdakul S., Yazici H.

ISRAEL MEDICAL ASSOCIATION JOURNAL , cilt.4, sa.11, ss.928-930, 2002 (SCI-Expanded, Scopus)

114. Evaluation of patients for tuberculosis prior to treatment with anti-tumor necrosis factor-α biological agents: Consensus meeting report March 2, 2002 / İstanbul

Akkoç N., DİRESKENELİ R. H., Ertenli I., FRESKO İ., Gül A., HAMURYUDAN V., et al.

Marmara Medical Journal , cilt.15, sa.4, ss.273-276, 2002 (Scopus, TRDizin) Sürdürülebilir Kalkınma

115. Colchicine neuromyopathy: A report of six cases

Altiparmak M. R., Pamuk O., Pamuk G., Hamuryudan V., Ataman R., Serdengecti K.

Clinical and Experimental Rheumatology , cilt.20, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

116. Glomerulonephritis in Behcet's disease: Report of seven cases and review of the literature

Altiparmak M. R., Tanverdi M., Pamuk O., Tunc R., Hamuryudan V.

CLINICAL RHEUMATOLOGY , cilt.21, sa.1, ss.14-18, 2002 (SCI-Expanded, Scopus)

117. Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study

Diri E., Mat C., Hamuryudan V., Yurdakul S., Hizli N., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES , cilt.60, sa.11, ss.1074-1076, 2001 (SCI-Expanded, Scopus)

118. A double-blind trial of colchicine in Behcet's syndrome

Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Hamuryudan V., Uysal O., et al.

ARTHRITIS AND RHEUMATISM , cilt.44, sa.11, ss.2686-2692, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. Behçet's disease: Diagnostic and prognostic aspects of neurological involvement

Siva A., Kantarci O., Saip S., Altintas A., Hamuryudan V., Islak C., et al.

Journal of Neurology , cilt.248, sa.2, ss.95-103, 2001 (SCI-Expanded, Scopus)

120. A reappraisal of amyloidosis in Behçet's syndrome.

Melikoglu M., Altiparmak M. R., Fresko I., Tunc R., Yurdakul S., Hamuryudan V., et al.

Rheumatology (Oxford, England) , cilt.40, sa.2, ss.212-5, 2001 (SCI-Expanded, Scopus)

121. Behcet disease

Yazici H., Yurdakul S., Hamuryudan V.

CURRENT OPINION IN RHEUMATOLOGY , cilt.13, sa.1, ss.18-22, 2001 (SCI-Expanded, Scopus)

122. Intestinal permeability in Behcet's syndrome

Fresko İ., Hamuryudan V., Demir M., Hizli N., Sayman H. B., Melikoglu M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.60, sa.1, ss.65-66, 2001 (SCI-Expanded, Scopus)

123. Occlusion of large cerebral arteries in Behcet's disease

Delil P., Ince B., Kocer N., Iplak C., Hamuryudan V., Oz B.

STROKE , cilt.31, sa.11, ss.2823, 2000 (SCI-Expanded, Scopus)

124. The 20 year prognosis of Behcet's Syndrome.

Kurai E., SEYAHİ N., Ozyazgan Y., Mat C., Yurdakul S., HAMURYUDAN V., et al.

ARTHRITIS AND RHEUMATISM , cilt.43, sa.9, 2000 (SCI-Expanded)

125. Behçet sendromunda antimikobakteriyal antikorlar

MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.

İnfeksiyon Dergisi(Turkish Journal of Infection) , cilt.13, sa.4, ss.527-529, 1999 (Hakemli Dergi)

126. CNS involvement in Neuro-Behcet syndrome: An MR study

Kocer N., Islak C., Siva A., Saip S., Akman C., Kantarci O., et al.

American Journal of Neuroradiology , cilt.20, sa.6, ss.1015-1024, 1999 (SCI-Expanded, Scopus)

127. The management of Behcet's syndrome

Fresko İ., Yurdakul S., Hamuryudan V., Ozyazgan Y., Mat C., Tanverdi M., et al.

Annales de Medecine Interne , cilt.150, sa.7, ss.576-581, 1999 (SCI-Expanded, Scopus)

128. A successful renal transplantation in Behcet's syndrome

Apaydin S., Erek E., Ulku U., Hamuryudan V., Yazici H., Sariyar M.

ANNALS OF THE RHEUMATIC DISEASES , cilt.58, sa.11, ss.719, 1999 (SCI-Expanded, Scopus)

129. Neutrophil chemotaxis in Behcet's syndrome

Tüzün B., Tuzun Y., Mat C., Yurdakul S., Hamuryudan V., Yazici H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.58, sa.10, ss.658, 1999 (SCI-Expanded, Scopus)

130. A reappraisal of amyloidosis in Behcet's syndrome

ALKAN MELİKOĞLU M., ALTIPARMAK M. R., FRESKO İ., Yurdakul S., HAMURYUDAN V., Yazici H.

ARTHRITIS AND RHEUMATISM , cilt.42, sa.9, 1999 (SCI-Expanded)

131. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome

Hamuryudan V., Fresko İ., Direskeneli H., Tenant M., Yurdakul S., Akoglu T., et al.

RHEUMATOLOGY , cilt.38, sa.8, ss.734-736, 1999 (SCI-Expanded, Scopus)

132. The management of Behcet's syndrome: How are we doing?

Yazici H., Yurdakul S., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.17, sa.2, ss.145-147, 1999 (SCI-Expanded, Scopus)

133. Behcet's syndrome

Yazici H., Yurdakul S., HAMURYUDAN V.

Current Opinion in Rheumatology , cilt.11, sa.1, ss.53-57, 1999 (SCI-Expanded, Scopus)

134. Behcet's syndrome - The cerrahpasa experience

Yazici H., Fresko I., Hamuryudan V., Mat C., Melikoglu M., Ozyazgan Y., et al.

RHEUMADERM , cilt.455, ss.135-140, 1999 (SCI-Expanded, Scopus)

135. Fibromyalgia in Behcet's syndrome

Yavuz S., Fresko İ., Hamuryudan V., Yurdakul S., Yazici H.

JOURNAL OF RHEUMATOLOGY , cilt.25, sa.11, ss.2219-2220, 1998 (SCI-Expanded, Scopus)

136. Mucocutaneous lesions in the Behcet syndrome

HAMURYUDAN V., Mat C., Yazici H.

ANNALS OF INTERNAL MEDICINE , cilt.129, sa.10, ss.836, 1998 (SCI-Expanded, Scopus)

137. The relation between joint involvement and skin lesions in patients with Behcet's syndrome.

Diri E., Mat C., Hamuryudan V., Yurdakul S., Yazici H.

ARTHRITIS AND RHEUMATISM , cilt.41, sa.9, 1998 (SCI-Expanded)

138. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial

Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., et al.

ANNALS OF INTERNAL MEDICINE , cilt.128, sa.6, ss.443-451, 1998 (SCI-Expanded, Scopus)

139. Wound healing in Behcet's syndrome

Mat M. C., Nazarbaghi M., Tuzun Y., Hamuryudan V., Hızlı N., Yurdakul S., et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.37, sa.2, ss.120-123, 1998 (SCI-Expanded, Scopus)

140. Genetic anticipation in Behcet's syndrome

Fresko İ., Soy M., Hamuryudan V., Yurdakul S., Yavuz S., Tumer Z., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.57, sa.1, ss.45-48, 1998 (SCI-Expanded, Scopus)

141. Von Willebrand factor antigen and angiotensin converting enzyme levels in Takayasu arteritis [3]

Kadioglu P., Hamuryudan V., Hekim N., Ozbakir F., Yurdakul S., Yazici H.

British Journal of Rheumatology , cilt.36, sa.8, ss.924-925, 1997 (SCI-Expanded, Scopus)

142. Topical cyclosporine-A for treatment of oral ulcers of Behcet's syndrome

Ergun T., Gurbuz O., Yurdakul S., Hamuryudan V., Bekiroglu N., Yazici H.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.36, sa.9, ss.720, 1997 (SCI-Expanded, Scopus)

143. Randomised and placebo controlled trial of two different doses of thalidomide in Behcet's syndrome

Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., et al.

ARTHRITIS AND RHEUMATISM , cilt.40, sa.9, ss.210, 1997 (SCI-Expanded)

144. Other forms of vasculitis and pseudovasculitis

Hamuryudan V., Ozdogan H., Yazici H.

BAILLIERES CLINICAL RHEUMATOLOGY , cilt.11, sa.2, ss.335-355, 1997 (SCI-Expanded, Scopus)

145. Azathioprine in Behcet's syndrome - Effects on long-term prognosis

Hamuryudan V., Ozyazgan Y., Hızlı N., Mat C., Yurdakul S., Tuzun Y., et al.

ARTHRITIS AND RHEUMATISM , cilt.40, sa.4, ss.769-774, 1997 (SCI-Expanded, Scopus)

146. Treatment of Behcet disease with pentoxifylline

Hamuryudan V., Ozyazgan Y., Yazici H.

ANNALS OF INTERNAL MEDICINE , cilt.126, sa.6, ss.494, 1997 (SCI-Expanded, Scopus)

147. Neuro-Behcet syndrome (NBS): Clinical and imaging features

SİVA A., Saip S., Kantarci O., HAMURYUDAN V., Kocer N., Islak C., et al.

NEUROLOGY , cilt.48, sa.3, ss.56001, 1997 (SCI-Expanded, Scopus)

148. Management of aneurysms in Behcet's syndrome: An analysis of 24 patients

Tuzun H. H., Besirli K., Sayin A., Vural F., Hamuryudan V., Hizli N., et al.

SURGERY , cilt.121, sa.2, ss.150-156, 1997 (SCI-Expanded, Scopus)

149. Calciphylaxis: A condition mimicking necrotizing vasculitis

Melikoglu M., Apaydin S., Hamuryudan V., Yurdakul S., Uygun N., Aki H., et al.

CLINICAL RHEUMATOLOGY , cilt.15, sa.5, ss.498-500, 1996 (SCI-Expanded, Scopus)

150. The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): A masked and controlled study

Ince A., Yazici Y., HAMURYUDAN V., Yazici H.

CLINICAL RHEUMATOLOGY , cilt.15, sa.5, ss.491-494, 1996 (SCI-Expanded, Scopus)

151. Paterji pozitifliğinin pikür süresi ile ilişkisi

MAT M. C., GÖKLER G., YURDAKUL S., TÜZÜN Y., YAZICI H., HAMURYUDAN V., et al.

CERRAHPAŞA TIP DERGİSİ , cilt.27, ss.94-97, 1996 (TRDizin)

152. Monocyte activity in Behcet's disease

Sahin S., Lawrence R., Direskeneli H., Hamuryudan V., Yazici H., Akoglu T.

Revmatologiia , cilt.35, sa.5, ss.424-429, 1996 (Scopus)

153. Gastrointestinal involvement in Behcet's syndrome: A controlled study

Yurdakul S., Tuzuner N., YURDAKUL I., Hamuryudan V., Yazici H.

ANNALS OF THE RHEUMATIC DISEASES , cilt.55, sa.3, ss.208-210, 1996 (SCI-Expanded, Scopus)

154. The ten-year mortality in Behcet's syndrome

Yazici H., Başaran G., Hamuryudan V., Hızlı N., Yurdakul S., Mat C., et al.

BRITISH JOURNAL OF RHEUMATOLOGY , cilt.35, sa.2, ss.139-141, 1996 (SCI-Expanded, Scopus)

155. Surgical therapy of pulmonary arterial aneurysms in Behcet's syndrome

Tuzun H. H., Hamuryudan V., Yildirim S., Besirli K., Yoruk Y., Yurdakul S., et al.

ANNALS OF THORACIC SURGERY , cilt.61, sa.2, ss.733-735, 1996 (SCI-Expanded, Scopus)

156. Epidemiology of Behcet's syndrome in Turkey

Tuzun Y., Yurdakul S., Ozyazgan Y., Hamuryudan V., Tuzun B., Yazici H.

International Journal of Dermatology , cilt.35, sa.9, ss.618-620, 1996 (SCI-Expanded, Scopus)

157. More on hepatitis c virus and behçet's syndrome

Benezra D., HAMURYUDAN V., SONSUZ A., Yurdakul S., Oguz A., Sametoglu F., et al.

New England Journal of Medicine , cilt.333, sa.5, ss.322-323, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

158. MORE ON HEPATITIS-C VIRUS AND BEHCETS-SYNDROME

HAMURYUDAN V., SONSUZ A., YURDAKUL S.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.333, sa.5, ss.322, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

159. INEFFICACY OF AZAPROPAZONE IN THE ACUTE ARTHRITIS OF BEHCETS-SYNDROME - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

MORAL F., HAMURYUDAN V., YURDAKUL S., YAZICI H.

CLINICAL AND EXPERIMENTAL DERMATOLOGY , cilt.13, sa.4, ss.493-495, 1995 (SCI-Expanded, Scopus)

160. BEHCETS-SYNDROME - HOW SHOULD WE TREAT IT

YAZICI H., YURDAKUL S., HAMURYUDAN V.

CLINICAL IMMUNOTHERAPEUTICS , cilt.3, sa.2, ss.102-107, 1995 (SCI-Expanded, Scopus)

161. ANTIENDOTHELIAL CELL ANTIBODIES, ENDOTHELIAL PROLIFERATION AND VON-WILLEBRAND-FACTOR ANTIGEN IN BEHCETS-DISEASE

DIRESKENELI H., KESER G., DCRUZ D., KHAMASHTA M., AKOGLU T., YAZICI H., et al.

CLINICAL RHEUMATOLOGY , cilt.14, sa.1, ss.55-61, 1995 (SCI-Expanded, Scopus)

162. THE PREVALENCE OF SJOGRENS-SYNDROME IN BEHCETS-SYNDROME

GUNAYDIN I., USTUNDAG C., KANER G., PAZARLI H., YURDAKUL S., HAMURYUDAN V., et al.

JOURNAL OF RHEUMATOLOGY , cilt.21, sa.9, ss.1662-1664, 1994 (SCI-Expanded, Scopus)

163. Systemic interferon α2b treatment in Behcets syndrome

HAMURYUDAN V., Moral F., Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., et al.

Journal of Rheumatology , cilt.21, sa.6, ss.1098-1100, 1994 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

164. SYSTEMIC INTERFERON-ALPHA-2B TREATMENT IN BEHCETS-SYNDROME

HAMURYUDAN V., Moral F., YURDAKUL S., MAT C., TUZUN Y., OZYAZGAN Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.21, sa.6, ss.1098-1100, 1994 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

165. Behçet hastalığı

YAZICI H., YURDAKUL S., TÜZÜN Y., ÖZYAZGAN Y., MAT M. C., HAMURYUDAN V.

BİLİM VE TEKNİK , sa.314, ss.25-29, 1994 (Hakemli Dergi)

166. The prevalence of Sjojgren's syndrome in Behcet's syndrome

Gunaydin I., Ustundag C., Kaner G., Pazarli H., Yurdakul S., HAMURYUDAN V., et al.

Journal of Rheumatology , cilt.21, sa.9, ss.1662-1664, 1994 (SCI-Expanded, Scopus)

167. PULMONARY ARTERIAL ANEURYSMS IN BEHCETS-SYNDROME - A REPORT OF 24 CASES

HAMURYUDAN V., YURDAKUL S., MORAL F., NUMAN F., TUZUN H., TUZUNER N., et al.

BRITISH JOURNAL OF RHEUMATOLOGY , cilt.33, sa.1, ss.48-51, 1994 (SCI-Expanded, Scopus)